ALKEM LABS LTD FDA Approval ANDA 206402

ANDA 206402

ALKEM LABS LTD

FDA Drug Application

Application #206402

Application Sponsors

ANDA 206402ALKEM LABS LTD

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL600MG0GABAPENTINGABAPENTIN
002TABLET;ORAL800MG0GABAPENTINGABAPENTIN

FDA Submissions

UNKNOWN; ORIG1AP2015-12-23STANDARD
LABELING; LabelingSUPPL3AP2021-04-29STANDARD
LABELING; LabelingSUPPL5AP2021-04-29STANDARD
LABELING; LabelingSUPPL14AP2021-04-29STANDARD
LABELING; LabelingSUPPL17AP2021-04-29STANDARD
LABELING; LabelingSUPPL20AP2022-03-31STANDARD

Submissions Property Types

ORIG1Null15
SUPPL3Null15
SUPPL5Null7
SUPPL14Null7
SUPPL17Null15
SUPPL20Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206402
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"GABAPENTIN","activeIngredients":"GABAPENTIN","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"GABAPENTIN","activeIngredients":"GABAPENTIN","strength":"800MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/23\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"01\/09\/2017","submission":"SUPPL-1","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2017-01-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.